|Podcasts|June 24, 2021

Episode 85: Managing the Dynamics of Oncology

Teresa Bitetti, President of Takeda Pharmaceuticals’ Global Oncology Business Unit, talks about her experience as a leader in the oncology space and what that entails in today’s environment.

Teresa Bitetti, President of the Global Oncology Business Unit at Takeda Pharmaceuticals discusses the dynamic nature of the oncology space, and how leadership style and corporate culture play an important role in managing such a business.

You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.
Pharmaceutical Executive Daily
FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research process, and Ignite Proteomics’ Dr. Brian Corgiat on adjusting for tumor mutations in treatment decisions.